How much is Solid Biosciences worth in 2026?

Solid Biosciences has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Solid Biosciences raised?

Solid Biosciences has raised N/A in total funding across 3 funding rounds.

Solid Biosciences

Drug Discovery

Solid Biosciences valuation and funding history | Last updated: February 19, 2025 | 3 funding rounds

Current Valuation

N/A

As of February 19, 2025

Total Funding Raised

N/A

Across 3 rounds

Last Round

PIPE

$144.0M

Last Funding

Feb 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 19, 2025	PIPE	$144.0M	N/A	-
January 8, 2024	PIPE	$108.9M	N/A	-
December 5, 2022	PIPE	$75.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Solid Biosciences is currently valued at N/A as of February 19, 2025.

Track Solid Biosciences Valuation Updates

Get notified when Solid Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Solid Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Solid Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Solid Biosciences Worth in 2026?

Solid Biosciences is a leading private company in the Drug Discovery sector. Track Solid Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Solid Biosciences Valuation is Determined

Private company valuations like Solid Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.